Mayo Clinic researchers developed an experimental nanotherapy that delivers two cancer drugs directly to brain tumors, ...

Like tiny superheroes, small, naturally occurring segments of RNA can block multiple molecular paths that cancer cells use to ...

Progressing vision to expand the reach of targeted radiopharmaceuticals to large patient populationsAnticipating multiple milestones in the next 12 months, including initiation of Phase 1b clinical tr ...

Bayer BAYRY’s wholly owned subsidiary, AskBio Inc., announced the completion of patient enrollment in the mid-stage GenePHIT ...

A metabolic enzyme found in the support cells surrounding tumors may hold the key to predicting which cancer patients will ...

Acquisition will bring two differentiated commercialized immunology medicines to Biogen with EMPAVELI® FDA-approved in three indications, ...

A 2026 informational overview of BackRestore's Regenesis Tri-Therapy System for chronic lower back pain, herniated disc support, and pinched nerve relief - how the company describes its home spinal ...

Nationally, there has been a rise in the number of children and adolescents with congenital and acquired heart disease ...

Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced it has acquired View Point Medical, Inc. (View Point). Through a merger transaction, View Point is ...

Discusses Positive Topline Results from Elegrobart REVEAL-1 Phase III Trial in Active Thyroid Eye Disease March 30, ...

Positive high-level results from the EMERALD-3 Phase III trial showed AstraZeneca's Imfinzi (durvalumab) in combination with Imjudo (tremelimumab ...

After a string of denials for rare disease treatments, the FDA greenlit a drug for Hunter syndrome, a progressive illness ...